Treatment characteristics of patients with symptomatic MM
| Characteristic . | N . |
|---|---|
| Total no. of patients | 101 |
| Treatment | |
| Standard-dose chemotherapy | 48 |
| High-dose chemotherapy | 53 |
| Treatment completion | |
| Completed therapy course | 89 |
| Premature discontinuation | 12 |
| Pretreatment and posttreatment sample available | 50 |
| Treatment | |
| Standard-dose chemotherapy | 29 |
| High-dose chemotherapy | 21 |
| Response according to EBMT criteria37 | |
| Complete response | 5 |
| Partial response | 36 |
| No change | 4 |
| Progressive disease | 5 |
| Characteristic . | N . |
|---|---|
| Total no. of patients | 101 |
| Treatment | |
| Standard-dose chemotherapy | 48 |
| High-dose chemotherapy | 53 |
| Treatment completion | |
| Completed therapy course | 89 |
| Premature discontinuation | 12 |
| Pretreatment and posttreatment sample available | 50 |
| Treatment | |
| Standard-dose chemotherapy | 29 |
| High-dose chemotherapy | 21 |
| Response according to EBMT criteria37 | |
| Complete response | 5 |
| Partial response | 36 |
| No change | 4 |
| Progressive disease | 5 |